Global Drug-Device Combination Products Market by Product (Antimicrobial Catheters, Drug Eluting Stents, Infusion Pumps), Application (Antimicrobial Application, Cancer Treatment, Cardiovascular Disorder), End-user - Forecast 2024-2030- Product Image

Sale

Global Drug-Device Combination Products Market by Product (Antimicrobial Catheters, Drug Eluting Stents, Infusion Pumps), Application (Antimicrobial Application, Cancer Treatment, Cardiovascular Disorder), End-user - Forecast 2024-2030

Report
189 Pages
June 2024
Region: Global
360iResearch™
ID: 5715527

UP TO €672EUR$697USD£571GBP OFF until Dec 31^st 2024

The Drug-Device Combination Products Market grew from USD 133.95 billion in 2023 to USD 144.59 billion in 2024. It is expected to continue growing at a CAGR of 8.09%, reaching USD 231.05 billion by 2030.

These products are designed to provide synergistic therapeutic benefits by integrating the pharmacological action of drugs with the physical performance of devices. The drug-device combination product offers innovative solutions for unmet medical needs or enhances existing therapies. Drug-device combination products deliver better patient outcomes compared to each component administered separately by combining drugs and devices into one product. This is primarily due to drug-targeted delivery at specific sites within the body, which increases efficacy while minimizing side effects or systemic toxicity. Incorporating advanced technologies, including smart sensors in these combination products, enables real-time monitoring and control over drug release profiles, which fosters personalized medicine approaches tailored to individual patient needs. Moreover, the prevalence of chronic diseases, including diabetes and heart ailments, has raised the need for minimally invasive and targeted treatment options. Ongoing efforts by regulatory authorities, including the U.S. FDA, to streamline approval processes for innovative combination products provide a favorable environment for manufacturers. However, complex regulatory frameworks and the high cost of research and development (R&D) activities significantly impede the adoption of drug-device combination products. In addition, manufacturers invest in research and development activities to address unmet clinical needs in areas such as targeted drug delivery systems or bioresorbable implants. Exploring new drug-device combinations to fight antibiotic-resistant infections or enhance cancer therapies is expected to create prospects for developing drug-device combination products.

Regional Insights

In the Americas, there is a growing need for drug-device combination products due to the increasing prevalence of chronic diseases, the aging population, technological advancements, and favorable reimbursement policies. The U.S. Food and Drug Administration (FDA) has been actively involved in approving patents and supporting research initiatives to develop drug-device combination products. In the Asia-Pacific, countries including China, Japan, India, and South Korea focus on cost-effective solutions to address unmet medical needs for their large patient pool suffering from chronic illnesses such as diabetes or cardiovascular diseases. China's National Medical Products Administration (NMPA) released new guidelines on clinical evaluation reports for medical devices promoting advancements in drug-device combination products. In addition, Japan's Pharmaceuticals and Medical Devices (PMD) Act ensures the quality, efficacy, and safety of pharmaceuticals, medical devices, and similar products. European Union countries have witnessed a surge in investment within biotechnology and medical device sectors, improving research activities on drug-device combination products. The European Medicines Agency (EMA) plays a vital role in evaluating these products' safety and efficacy. Major players collaborate with academic institutions to develop innovative solutions catering to specific regional demands. In the Middle East and Africa region, several regional governments focus on investing in healthcare infrastructure development that provides future growth opportunities for developing drug-device combination products.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Drug-Device Combination Products Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

Prevalence of chronic disease and emphasis on targeted treatments
Favorable government approvals for various drug-device combination products
Preference for minimally invasive surgeries and use of antimicrobial and drug-eluting stents

Market Restraints

Dosing and operational limitations of drug-device combination products

Market Opportunities

Technological advancements in drug-device combination products
Amalgamation strategies to expand drug-device combination product commercialization

Market Challenges

Regulatory hurdles associated with approval of customized combination products

Market Segmentation Analysis

Product: Increasing use of drug eluting stents and orthopedic combination products in surgical procedures
Application: Emerging need of drug-device combination products for efficient treatment across oncology and cardiovascular disorder

Industry Insights

Market Disruption Analysis
Porter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Drug-Device Combination Products Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Drug-Device Combination Products Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Nemera and Nelson Labs Europe trengthen partnership to offer integrated services to customer

Nemera, a provider of drug delivery device solutions and combination product services, announced strengthening its existing partnership with Nelson Labs Europe, a significant player across the globe in microbiological and analytical chemistry testing for the medical device and pharmaceutical industries. This non-exclusive collaboration allowed Nemera to access extractables & leachables, biocompatibility, microbiology, and chemical testing from Nelson Labs, delivering an integrated service offering to clients for their drug/device combination products and accelerating their market entry. They anticipated a productive collaboration, enhancing their mutual capabilities in providing superior solutions in the medical device and pharmaceutical sectors.

Kindeva and Meridian Combine: Create Leading Drug-Device Combination Product CDMO

Kindeva Drug Delivery and Meridian Medical Technologies completed their merger, resulting in the formation of a global Contract Development and Manufacturing Organization (CDMO) specializing in drug-device combination products. This merger aimed to expand the range of drug delivery capabilities by leveraging expertise and technology across parenteral, inhalation, transdermal, and intradermal administration routes.

Terumo Announces Launch of Drug-Device Combination Product Co-Developed with Kyowa Kirin

Terumo Corporation launched G-Lasta Subcutaneous Injection 3.6 mg BodyPod, a novel drug-device combination product created in collaboration with Kyowa Kirin Co., Ltd. The activated device is attached to the patient's body at the clinic during chemotherapy and automatically administers the drug approximately 27 hours later. The introduction of this advanced drug-device combination product streamlines treatment and reduces patient burden associated with post-chemotherapy visits.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Drug-Device Combination Products Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Drug-Device Combination Products Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Braile Biomédica, Cardinal Health, Inc., CODAN Companies, Cook Group Incorporated, F. Hoffmann-La Roche AG, Fresenius Kabi, ICU Medical, Inc., InfuTronix, InSitu Technologies Inc., Insulet Corporation, JMS North America Corporation, Lepu Medical Technology Company, Medtronic PLC, MicroPort Scientific Corporation, Novartis AG, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., SOOIL Developments Co., Ltd., Stryker Corporation, Teleflex Incorporated, Terumo Corporation, Viatris Inc., W. L. Gore & Associates Inc., and Zyno Medical.

Market Segmentation & Coverage

This research report categorizes the Drug-Device Combination Products Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product

Antimicrobial Catheters
Drug Eluting Stents
Infusion Pumps
Inhalers
Orthopedic Combination Products
Photodynamic Therapy Devices
Prefilled Syringes
Transdermal Patches
Wound Care Products

Application

Antimicrobial Application
Cancer Treatment
Cardiovascular Disorder
Diabetes
Respiratory Problem

End-user

Ambulatory Surgery Centers
Home Care Settings
Hospital & Clinic

Region

Americas

Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas

Asia-Pacific

Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam

Europe, Middle East & Africa

Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of chronic disease and emphasis on targeted treatments
5.1.1.2. Favorable government approvals for various drug-device combination products
5.1.1.3. Preference for minimally invasive surgeries and use of antimicrobial and drug-eluting stents
5.1.2. Restraints
5.1.2.1. Dosing and operational limitations of drug-device combination products
5.1.3. Opportunities
5.1.3.1. Technological advancements in drug-device combination products
5.1.3.2. Amalgamation strategies to expand drug-device combination product commercialization
5.1.4. Challenges
5.1.4.1. Regulatory hurdles associated with approval of customized combination products
5.2. Market Segmentation Analysis
5.2.1. Product: Increasing use of drug eluting stents and orthopedic combination products in surgical procedures
5.2.2. Application: Emerging need of drug-device combination products for efficient treatment across oncology and cardiovascular disorder
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Drug-Device Combination Products Market, by Product

6.1. Introduction
6.2. Antimicrobial Catheters
6.3. Drug Eluting Stents
6.4. Infusion Pumps
6.5. Inhalers
6.6. Orthopedic Combination Products
6.7. Photodynamic Therapy Devices
6.8. Prefilled Syringes
6.9. Transdermal Patches
6.10. Wound Care Products

7. Drug-Device Combination Products Market, by Application

7.1. Introduction
7.2. Antimicrobial Application
7.3. Cancer Treatment
7.4. Cardiovascular Disorder
7.5. Diabetes
7.6. Respiratory Problem

8. Drug-Device Combination Products Market, by End-user

8.1. Introduction
8.2. Ambulatory Surgery Centers
8.3. Home Care Settings
8.4. Hospital & Clinic

9. Americas Drug-Device Combination Products Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Drug-Device Combination Products Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Drug-Device Combination Products Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Nemera and Nelson Labs Europe trengthen partnership to offer integrated services to customer
12.3.2. Kindeva and Meridian Combine: Create Leading Drug-Device Combination Product CDMO
12.3.3. Terumo Announces Launch of Drug-Device Combination Product Co-Developed with Kyowa Kirin
12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

13.1. Key Company Profiles
13.2. Key Product Portfolio

List of Figures

FIGURE 1. DRUG-DEVICE COMBINATION PRODUCTS MARKET RESEARCH PROCESS
FIGURE 2. DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. DRUG-DEVICE COMBINATION PRODUCTS MARKET DYNAMICS
FIGURE 7. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. DRUG-DEVICE COMBINATION PRODUCTS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. DRUG-DEVICE COMBINATION PRODUCTS MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. DRUG-DEVICE COMBINATION PRODUCTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ANTIMICROBIAL CATHETERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ANTIMICROBIAL CATHETERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INHALERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INHALERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ORTHOPEDIC COMBINATION PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ORTHOPEDIC COMBINATION PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PHOTODYNAMIC THERAPY DEVICES, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PHOTODYNAMIC THERAPY DEVICES, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PREFILLED SYRINGES, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PREFILLED SYRINGES, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY WOUND CARE PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY WOUND CARE PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ANTIMICROBIAL APPLICATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ANTIMICROBIAL APPLICATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CANCER TREATMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CANCER TREATMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CARDIOVASCULAR DISORDER, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CARDIOVASCULAR DISORDER, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DIABETES, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DIABETES, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY RESPIRATORY PROBLEM, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY RESPIRATORY PROBLEM, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY HOSPITAL & CLINIC, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY HOSPITAL & CLINIC, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 48. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 49. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 50. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 51. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 52. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 53. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 54. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 55. ARGENTINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 56. ARGENTINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 57. ARGENTINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 58. ARGENTINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 59. ARGENTINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 60. ARGENTINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 61. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 62. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 63. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 64. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 65. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 66. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 67. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 68. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 69. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 70. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 71. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 72. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 73. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 74. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 75. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 76. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 77. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 78. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 79. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 80. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 81. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 82. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 83. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 84. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 85. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 86. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 88. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 90. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 92. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 94. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 95. AUSTRALIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 96. AUSTRALIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 97. AUSTRALIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 98. AUSTRALIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 99. AUSTRALIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 100. AUSTRALIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 101. CHINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 102. CHINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 103. CHINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 104. CHINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 105. CHINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 106. CHINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 107. INDIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 108. INDIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 109. INDIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 110. INDIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 111. INDIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 112. INDIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 113. INDONESIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 114. INDONESIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 115. INDONESIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 116. INDONESIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 117. INDONESIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 118. INDONESIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 119. JAPAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 120. JAPAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 121. JAPAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 122. JAPAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 123. JAPAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 124. JAPAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 125. MALAYSIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 126. MALAYSIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 127. MALAYSIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 128. MALAYSIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 129. MALAYSIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 130. MALAYSIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 131. PHILIPPINES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 132. PHILIPPINES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 133. PHILIPPINES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 134. PHILIPPINES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 135. PHILIPPINES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 136. PHILIPPINES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 137. SINGAPORE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 138. SINGAPORE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 139. SINGAPORE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 140. SINGAPORE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 141. SINGAPORE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 142. SINGAPORE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 143. SOUTH KOREA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 144. SOUTH KOREA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 145. SOUTH KOREA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 146. SOUTH KOREA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 147. SOUTH KOREA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 148. SOUTH KOREA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 149. TAIWAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 150. TAIWAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 151. TAIWAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 152. TAIWAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 153. TAIWAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 154. TAIWAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 155. THAILAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 156. THAILAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 157. THAILAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 158. THAILAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 159. THAILAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 160. THAILAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 161. VIETNAM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 162. VIETNAM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 163. VIETNAM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 164. VIETNAM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 165. VIETNAM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 166. VIETNAM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 175. DENMARK DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 176. DENMARK DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 177. DENMARK DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 178. DENMARK DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 179. DENMARK DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 180. DENMARK DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 181. EGYPT DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 182. EGYPT DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 183. EGYPT DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 184. EGYPT DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 185. EGYPT DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 186. EGYPT DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 187. FINLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 188. FINLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 189. FINLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 190. FINLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 191. FINLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 192. FINLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 193. FRANCE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 194. FRANCE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 195. FRANCE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 196. FRANCE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 197. FRANCE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 198. FRANCE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 199. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 200. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 201. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 202. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 203. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 204. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 205. ISRAEL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 206. ISRAEL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 207. ISRAEL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 208. ISRAEL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 209. ISRAEL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 210. ISRAEL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 211. ITALY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 212. ITALY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 213. ITALY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 214. ITALY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 215. ITALY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 216. ITALY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 217. NETHERLANDS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 218. NETHERLANDS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 219. NETHERLANDS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 220. NETHERLANDS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 221. NETHERLANDS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 222. NETHERLANDS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 223. NIGERIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 224. NIGERIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 225. NIGERIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 226. NIGERIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 227. NIGERIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 228. NIGERIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 229. NORWAY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 230. NORWAY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 231. NORWAY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 232. NORWAY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 233. NORWAY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 234. NORWAY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 235. POLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 236. POLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 237. POLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 238. POLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 239. POLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 240. POLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 241. QATAR DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 242. QATAR DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 243. QATAR DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 244. QATAR DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 245. QATAR DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 246. QATAR DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 247. RUSSIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 248. RUSSIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 249. RUSSIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 250. RUSSIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 251. RUSSIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 252. RUSSIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 253. SAUDI ARABIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 254. SAUDI ARABIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 255. SAUDI ARABIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 256. SAUDI ARABIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 257. SAUDI ARABIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 258. SAUDI ARABIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 260. SOUTH AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 261. SOUTH AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 262. SOUTH AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 263. SOUTH AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 264. SOUTH AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 265. SPAIN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 266. SPAIN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 267. SPAIN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 268. SPAIN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 269. SPAIN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 270. SPAIN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 271. SWEDEN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 272. SWEDEN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 273. SWEDEN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 274. SWEDEN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 275. SWEDEN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 276. SWEDEN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 277. SWITZERLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 278. SWITZERLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 279. SWITZERLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 280. SWITZERLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 281. SWITZERLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 282. SWITZERLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 283. TURKEY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 284. TURKEY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 285. TURKEY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 286. TURKEY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 287. TURKEY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 288. TURKEY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 296. UNITED KINGDOM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 298. UNITED KINGDOM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 300. UNITED KINGDOM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 301. DRUG-DEVICE COMBINATION PRODUCTS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 302. DRUG-DEVICE COMBINATION PRODUCTS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

AbbVie Inc.
B. Braun SE
Baxter International Inc.
Becton, Dickinson and Company
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
Braile Biomédica
Cardinal Health, Inc.
CODAN Companies
Cook Group Incorporated
F. Hoffmann-La Roche AG
Fresenius Kabi
ICU Medical, Inc.
InfuTronix
InSitu Technologies Inc.
Insulet Corporation
JMS North America Corporation
Lepu Medical Technology Company
Medtronic PLC
MicroPort Scientific Corporation
Novartis AG
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
SOOIL Developments Co., Ltd.
Stryker Corporation
Teleflex Incorporated
Terumo Corporation
Viatris Inc.
W. L. Gore & Associates Inc.
Zyno Medical

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	189
Published	June 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 144.59 Billion
Forecasted Market Value ( USD ) by 2030	$ 231.05 Billion
Compound Annual Growth Rate	8.0%
Regions Covered	Global
No. of Companies Mentioned	29

PURCHASE OPTIONS

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3418EUR$3,545USD£2,904GBP €3798EUR$3,939USD£3,227GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€4295EUR$4,454USD£3,649GBP €4772EUR$4,949USD£4,054GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€6048EUR$6,272USD£5,138GBP €6720EUR$6,969USD£5,709GBP